Utama › Penyakit Crohn › Iowa
Kajian klinikal Penyakit Crohn di Iowa
8 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi di Iowa.
Bandar di Iowa
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Iowa Digestive Disease Center ( Site 5007), Clive
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Heartland Medical Research Inc, Clive
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07499232A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- The University of Iowa Hospitals & Clinics, Iowa City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06233461An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Heartland Medical Research, Inc.-Site Number: 8400134, Clive
- Digestive Health Research Center-Site Number: 8400096, Waterloo
Mengambil pesertaFasa 3
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Iowa, Iowa City
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07237516Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- University of Iowa Health Care, Iowa City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Apr 2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400025, Iowa City
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06958536Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Iowa, Iowa City
Mengambil pesertaFasa 1/2
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.